Compare PRK & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRK | RGC |
|---|---|---|
| Founded | 1908 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.1B |
| IPO Year | 1996 | 2020 |
| Metric | PRK | RGC |
|---|---|---|
| Price | $191.67 | $5.43 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $184.00 | N/A |
| AVG Volume (30 Days) | 67.5K | ★ 147.9K |
| Earning Date | 04-24-2026 | 10-31-2025 |
| Dividend Yield | ★ 2.61% | N/A |
| EPS Growth | ★ 19.21 | N/A |
| EPS | ★ 5.64 | N/A |
| Revenue | ★ $664,421,000.00 | N/A |
| Revenue This Year | $24.26 | N/A |
| Revenue Next Year | $3.63 | N/A |
| P/E Ratio | $34.63 | ★ N/A |
| Revenue Growth | ★ 2.92 | N/A |
| 52 Week Low | $149.06 | $4.51 |
| 52 Week High | $215.00 | $69.00 |
| Indicator | PRK | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 36.60 | 40.59 |
| Support Level | $181.01 | $4.91 |
| Resistance Level | $192.77 | $6.22 |
| Average True Range (ATR) | 4.14 | 0.35 |
| MACD | -1.97 | 0.17 |
| Stochastic Oscillator | 8.62 | 33.95 |
Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. The company provides the following principal services: the acceptance of deposits for demand, savings and time accounts; commercial, industrial, consumer and real estate lending, including installment loans, credit cards (which are largely offered through a third party), home equity lines of credit and commercial leasing; trust and wealth management services; cash management; safe deposit operations; electronic funds transfers; and a variety of additional banking-related services.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.